Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9597357 T cell modifying compounds and uses thereof

Patent 9597357 was granted and assigned to Sangamo Biosciences Inc. on March, 2017 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
October 10, 2013
Date of Patent
March 21, 2017
Patent Application Number
14051244
Patent Citations Received
‌
US Patent 12123032 CRISPR enzyme mutations reducing off-target effects
0
‌
US Patent 12006508 Methods and products for expressing proteins in cells
0
‌
US Patent 12018275 Delivery and use of the CRISPR-CAS systems, vectors and compositions for hepatic targeting and therapy
0
‌
US Patent 12110500 Universal donor stem cells and related methods
0
‌
US Patent 11690921 Delivery of target specific nucleases
0
‌
US Patent 11708572 Acoustic cell separation techniques and processes
0
‌
US Patent 11759480 Compositions and methods for CAR T cell therapy
‌
US Patent 11779602 Methods of use for CAR T cells
‌
US Patent 11834509 Thymic stromal lymphopoietin receptor-specific chimeric antigen receptors and methods using same
0
‌
US Patent 11850262 Compositions and methods for CAR T cell therapy
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9597357
Patent Primary Examiner
‌
Ilia Ouspenski

Find more entities like US Patent 9597357 T cell modifying compounds and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.